Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01361
Full Text
Open PDFAbstract
Available in full text
Date
December 4, 2019
Authors
Publisher
Frontiers Media SA